Details
Originalsprache | Englisch |
---|---|
Aufsatznummer | 582052 |
Fachzeitschrift | Frontiers in Bioengineering and Biotechnology |
Jahrgang | 8 |
Publikationsstatus | Veröffentlicht - 23 Sept. 2020 |
Extern publiziert | Ja |
Abstract
Monoterpenoids, such as the plant metabolite geraniol, are of high industrial relevance since they are important fragrance materials for perfumes, cosmetics, and household products. Chemical synthesis or extraction from plant material for industry purposes are complex, environmentally harmful or expensive and depend on seasonal variations. Heterologous microbial production offers a cost-efficient and sustainable alternative but suffers from low metabolic flux of the precursors and toxicity of the monoterpenoid to the cells. In this study, we evaluated two approaches to counteract both issues by compartmentalizing the biosynthetic enzymes for geraniol to the peroxisomes of Saccharomyces cerevisiae as production sites and by improving the geraniol tolerance of the yeast cells. The combination of both approaches led to an 80% increase in the geraniol titers. In the future, the inclusion of product tolerance and peroxisomal compartmentalization into the general chassis engineering toolbox for monoterpenoids or other host-damaging, industrially relevant metabolites may lead to an efficient, low-cost, and eco-friendly microbial production for industrial purposes.
ASJC Scopus Sachgebiete
- Chemische Verfahrenstechnik (insg.)
- Bioengineering
- Biochemie, Genetik und Molekularbiologie (insg.)
- Biotechnologie
- Ingenieurwesen (insg.)
- Biomedizintechnik
- Medizin (insg.)
- Histologie
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Frontiers in Bioengineering and Biotechnology, Jahrgang 8, 582052, 23.09.2020.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Production of the Fragrance Geraniol in Peroxisomes of a Product-Tolerant Baker's Yeast
AU - Gerke, Jennifer
AU - Frauendorf, Holm
AU - Schneider, Dominik
AU - Wintergoller, Maxim
AU - Hofmeister, Thomas
AU - Poehlein, Anja
AU - Zebec, Ziga
AU - Takano, Eriko
AU - Scrutton, Nigel S.
AU - Braus, Gerhard H.
N1 - Funding information: The study was funded by the ERA-IB project “TERPENOSOME: Engineered compartments for monoterpenoid production using synthetic biology” (funding reference number 031A337A) and the Deutsche Forschungsgemeinschaft (DFG BR1502/19-1). ZZ, NS, and ET was funded by Biotechnology and Biological Sciences Research Council (BB/L027593/1) as part of the ERA-IB TERPENOSOME project. Funding for Open Access publication was supported by Göttingen University. We thank Verena Gro?e, Ute Neef, Verena Hofer-Preetz, and Mechthild B?meke for their technical assistance, Maria Vinaixia for the data evaluation of the initial GC-MS experiments, and Aroma Chemical Services International GmbH for providing geraniol as reference. We also thank Virginia W. Cornish for providing LW2591Y and Helge Bode and Blagovesta Popova for providing plasmids. Funding. The study was funded by the ERA-IB project ?TERPENOSOME: Engineered compartments for monoterpenoid production using synthetic biology? (funding reference number 031A337A) and the Deutsche Forschungsgemeinschaft (DFG BR1502/19-1). ZZ, NS, and ET was funded by Biotechnology and Biological Sciences Research Council (BB/L027593/1) as part of the ERA-IB TERPENOSOME project. Funding for Open Access publication was supported by G?ttingen University.
PY - 2020/9/23
Y1 - 2020/9/23
N2 - Monoterpenoids, such as the plant metabolite geraniol, are of high industrial relevance since they are important fragrance materials for perfumes, cosmetics, and household products. Chemical synthesis or extraction from plant material for industry purposes are complex, environmentally harmful or expensive and depend on seasonal variations. Heterologous microbial production offers a cost-efficient and sustainable alternative but suffers from low metabolic flux of the precursors and toxicity of the monoterpenoid to the cells. In this study, we evaluated two approaches to counteract both issues by compartmentalizing the biosynthetic enzymes for geraniol to the peroxisomes of Saccharomyces cerevisiae as production sites and by improving the geraniol tolerance of the yeast cells. The combination of both approaches led to an 80% increase in the geraniol titers. In the future, the inclusion of product tolerance and peroxisomal compartmentalization into the general chassis engineering toolbox for monoterpenoids or other host-damaging, industrially relevant metabolites may lead to an efficient, low-cost, and eco-friendly microbial production for industrial purposes.
AB - Monoterpenoids, such as the plant metabolite geraniol, are of high industrial relevance since they are important fragrance materials for perfumes, cosmetics, and household products. Chemical synthesis or extraction from plant material for industry purposes are complex, environmentally harmful or expensive and depend on seasonal variations. Heterologous microbial production offers a cost-efficient and sustainable alternative but suffers from low metabolic flux of the precursors and toxicity of the monoterpenoid to the cells. In this study, we evaluated two approaches to counteract both issues by compartmentalizing the biosynthetic enzymes for geraniol to the peroxisomes of Saccharomyces cerevisiae as production sites and by improving the geraniol tolerance of the yeast cells. The combination of both approaches led to an 80% increase in the geraniol titers. In the future, the inclusion of product tolerance and peroxisomal compartmentalization into the general chassis engineering toolbox for monoterpenoids or other host-damaging, industrially relevant metabolites may lead to an efficient, low-cost, and eco-friendly microbial production for industrial purposes.
KW - geraniol
KW - peroxisomes
KW - Saccharomyces cerevisiae
KW - compartmentalization
KW - tolerance
KW - monoterpenoids
UR - http://www.scopus.com/inward/record.url?scp=85092132727&partnerID=8YFLogxK
U2 - 10.3389/fbioe.2020.582052
DO - 10.3389/fbioe.2020.582052
M3 - Article
VL - 8
JO - Frontiers in Bioengineering and Biotechnology
JF - Frontiers in Bioengineering and Biotechnology
SN - 2296-4185
M1 - 582052
ER -